OrbiMed’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

OrbiMed’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-528,229	Closed	-$31.7M	–	183
2021 Q1	$31.7M	Sell	528,229 -952,711	-64%	-$34.5M	0.3%	81
2020 Q4	$22M	Hold	1,480,940	–	–	0.19%	97
2020 Q3	$17M	Buy	+1,480,940	New	+$25.3M	0.21%	93

OrbiMed's PAND Position: Q2 2021 in Review

OrbiMed sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 528,229 shares — an estimated $31.7M sold.

OrbiMed first reported a position in PAND in Q3 2020 and held it in 3 quarters. The position peaked at $31.7M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

OrbiMed reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
OrbiMed sold 528,229 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $31.7M.
OrbiMed first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 3 quarters.
OrbiMed's Pandion Therapeutics Inc. Common Stock position peaked at $31.7M in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on OrbiMed's 13F filing for Q2 2021, filed 16 Aug 2021.